mounjaro tirzepatide prescribing information fda label pdf FDA approves Lilly's Mounjaro™ (tirzepatide)

Given that it has two different mechanisms of action, it appears to have a more significant effect on weight and blood sugar than GLP-1 agonist drugs alone, such as semaglutide or liraglutide, which are both currently FDA-approved for sugar and weight control under different trade names

In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide

5-HTP Serotonin isnt just for your brain

Combining sensible dietary choices from the tirzepatide meal plan with your medication protocol maximizes results regardless of dose level

This process reduces risks and aligns with each patients health goals